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Dietary micronutrients intake 
and plasma fibrinogen levels 
in the general adult population
Alicia Padron‑Monedero1,2*, Fernando Rodríguez‑Artalejo2,3,4 & Esther Lopez‑Garcia2,3,4*
Plasma fibrinogen predicts cardiovascular and nonvascular mortality. However, there is limited 
population‑based evidence on the association between fibrinogen levels and dietary intakes of 
micronutrients possibly associated with inflammation status. Data were taken from the ENRICA 
study, conducted with 10,808 individuals representative of the population of Spain aged ≥ 18 years. 
Nutrient intake (vitamin A, carotenoids, vitamin B6, vitamin C, vitamin D, vitamin E, magnesium, 
selenium, zinc and iron) was estimated with a validated diet history, and plasma fibrinogen was 
measured under appropriate quality checks. Statistical analyses were performed with linear regression 
and adjusted for main confounders. The geometric means of fibrinogen (g/L) across increasing 
quintiles of nutrient intake were 3.22, 3.22, 3.22, 3.16, and 3.19 (p‑trend = 0.030) for vitamin E; 
3.23, 3.22, 3.20, 3.19, and 3.19 (p‑trend = 0.047) for magnesium; and 3.24, 3.22, 3.19, 3.21, and 3.19 
(p‑trend = 0.050) for iron. These inverse associations were more marked in participants with abdominal 
obesity and aged ≥ 60 years, but lost statistical significance after adjustment for other nutrients. 
Although dietary intakes of vitamin E, magnesium and iron were inversely associated with fibrinogen 
levels, clinical implications of these findings are uncertain since these results were of very small 
magnitude and mostly explained by intake levels of other nutrients.
Plasma fibrinogen is a potent marker of inflammation and  coagulation1. This is important because inflammation 
is one of the mechanistic pillars of  ageing2,3 that are shared by age-related diseases, including metabolic  diseases3. 
In fact, metaflammation (metabolic inflammation accompanying metabolic diseases) is thought to be the form of 
chronic inflammation that is driven by nutrient excess or overnutrition, which characterizes abdominal  obesity3, 
and it could be due to the activation of visceral adipose tissue  macrophages3. Metaflammation has the same 
mechanism underpinning inflammaging (age-associated inflammation), which is the activation of the innate 
immune system in response to a variety of stimuli, including external pathogens, endogenous cell debris and 
misplaced molecules, nutrients and gut  microbiota3.
Inflammation damages  DNA2,4 and its  repair4, and disrupts intracellular  homeostasis4. As a result, chronic 
inflammatory responses predispose to most chronic  disorders2,5, including  atherosclerosis6,7, neoplastic 
 transformation4,5,8–10, neurologic  disorders5,  diabetes5,11, and cardiovascular  disease5,11. Accordingly, fibrino-
gen has been shown to predict cardiovascular disease  incidence1,12 and both cardiovascular and nonvascular 
 mortality13, and it is considered a potential therapeutic  target1.
Adequate nutrition has strong anti-inflammatory effects and plays a key role in healthy  aging5. Several plant-
sourced dietary patterns, rich in fruit, vegetables and grains, as well as healthy sources of dietary fats have been 
inversely associated with inflammation  markers14–20. Moreover, it has been suggested that the magnitude of the 
association between some nutrients and certain inflammatory markers could be stronger among populations with 
lifestyles and demographic factors associated with inflammation, like obesity and old  age14,21–23; thus individuals 
with the latter conditions might respond better to anti-inflammatory  diets22.
Some micronutrients found in these dietary patterns, like vitamin A, carotenoids, vitamin B6, vitamin C, vita-
min D, vitamin E, magnesium, selenium, zinc and iron, could be of interest because they have anti-inflammatory 
properties and/or antioxidant  roles24–28, they are co-factors of important antioxidant  enzymes29, or they have 
been previously associated with fibrinogen  levels30,31.
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A limited number of studies have observed inverse associations between plasma fibrinogen levels and the 
dietary intake of vitamin  E30,  magnesium31, and  iron30. By contrast, some studies did not find inverse associations 
between plasma fibrinogen and the dietary intake of  carotenoids32,33, vitamin  C15,32,33, vitamin  E32,33,  magnesium32, 
 selenium33,  zinc32,33, and  iron32.
Moreover, as far as we know, no previous study has assessed the association between the dietary intake of some 
of the micronutrients of interest (vitamin A or vitamin B6) with plasma fibrinogen levels. There is only some 
information of a possible inverse association from studies using serum levels of vitamin  A22,  carotenoids22,34,35, 
vitamin  B630, vitamin  C15,36, vitamin  E22,30 and  iron30 and plasma fibrinogen levels.
Therefore, evidence on these associations is inconclusive; also, to our knowledge, no previous population-
based study that reported an inverse association with fibrinogen, has accounted for the intake of the other micro-
nutrients or has compared the magnitude of these associations between individuals with different inflammatory 
status, such as younger and older adults or people with obesity and without. Thus, this study aimed to assess, 
in a large sample representative of the adult population of a whole country, the associations between the intake 
of the above micronutrients and fibrinogen levels after adjusting for main confounders, and to examine if these 
associations vary with age and abdominal obesity.
Methods
Study design and participants. Data were taken from the ENRICA study, whose methods have been 
reported  elsewhere37. Briefly, ENRICA was a cross-sectional study conducted in 2008–2010 among 12,883 indi-
viduals representative of the non-institutionalized population of Spain aged 18 years and  older37. Study partici-
pants were selected by multistage clustered random sampling. The sample was first stratified by province and 
by size of municipality. Clusters were then randomly selected in two stages: municipalities and census sections. 
Finally, the households within each section were selected by random telephone dialing. Subjects in the house-
holds were selected proportionally to the distribution of the population of Spain by sex and  age37.
Rodriguez-Artalejo et al. previously reported that data collection was conducted by trained and certified 
staff in three  stages37. First, a phone interview was used to obtain data on sociodemographic variables, lifestyle, 
health status and morbidity. In the second stage (2–4 weeks after the interview), a home visit was conducted to 
collect blood and urine samples and to perform a physical exam. In a subsequent home visit (third stage), food 
consumption was assessed with the diet history, and information was obtained on drug treatments. The mean 
time between the second and third stage was 10 days.
The study response rate was 51%, which is within the range of response rates in National Health Interview 
and Examination Surveys in  Europe38.
All methods were carried out in accordance with relevant guidelines and regulations and all protocols of the 
ENRICA study were approved by the Clinical Research Ethics Committees of the University Hospital ‘La Paz’ 
in Madrid and the Hospital ‘Clinic’ in Barcelona. All study participants provided written informed consent.
Study variables. Diet. Food consumption was obtained with the Diet History ENRICA (DH-ENRICA), a 
validated diet history developed from the one used in the EPIC (European Prospective Investigation into Cancer 
and Nutrition) Spanish  cohort39. The DH-ENRICA is a computerized questionnaire that it is administered by 
a trained interviewer. Respondents are asked about food consumption during a typical week of the preceding 
year. The interview begins with the question: “What do you usually have to eat when you get up?” and continues 
asking about usual consumption on the six main intake occasions (when getting up, breakfast, mid-morning, 
lunch, mid-afternoon and dinner) and between those occasions, like snacking and going out for a drink. The 
DH-ENRICA allows to collect standardized information on 861 foods that can be cooked in 29 different ways 
(including mixed forms of cooking and food preservation methods). The software includes 127 sets of digitized 
photographs to estimate the size of food portions and provides assistance, if needed, to correctly classify some 
foods. The average time to complete a diet history is 45 min per participant.
The dietary intakes of the micronutrients, the macronutrients and the energy intake are estimated, by the DH-
ENRICA software, from standard food composition  tables40–44. Moreover, the DH-ENRICA software highlights 
weather nonrealistic values (including energy intake among other dietary measurements) were  registered39.
In a previous validation paper from our research  group39, micronutrient intakes from the diet history were 
compared against the mean of seven 24-h recalls during one year (as a gold standard), and the correlation coef-
ficients were 0.43 for carotenoids, 0.50 for vitamin B6, 0.52 for vitamin E, 0.66 for vitamin C, 0.46 for magnesium, 
and 0.49 for  iron39.
Fibrinogen. Plasma fibrinogen concentration (g/L) was determined in a 12-h fasting blood sample by the coag-
ulation method. The Centre of Biological Diagnosis (CBD) of the Hospital Clinic in Barcelona performed the 
determination with appropriate quality controls.
Other variables. We obtained information on potential confounders that have been associated with plasma 
and dietary micronutrient  levels15,45 and/or plasma fibrinogen  levels1,12,13,30,46. These variables included age, sex, 
educational level (primary, secondary and university studies), smoking (never, former, and current-smoker), 
and physical activity at leisure time (metabolic equivalent hours/week) as assessed with the validated EPIC-
Spain  questionnaire47. We also obtained alcohol intake with the diet history, which collected data of 34 types of 
alcoholic beverages. Total alcohol intake was expressed in g/d; men with an average intake ≥ 40 g/d, and women 
with ≥ 24 g/d, were classified as heavy  drinkers48. Weight, height and waist circumference were measured under 
standardized conditions. Body mass index (BMI) was calculated as weight (kg) divided by square height (m), 
and obesity was defined as BMI ≥ 30 kg/m2. Abdominal obesity was defined as waist circumference > 102 cm in 
3
Vol.:(0123456789)
Scientific Reports |         (2021) 11:3843  | https://doi.org/10.1038/s41598-021-83217-w
www.nature.com/scientificreports/
men and > 88 cm in  women49. Blood pressure was measured under standardized  conditions37. Hypertension was 
defined as systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg or the use of antihyperten-
sive treatment. Serum glucose (mg/dL) was determined by the glucose oxidase method. Diabetes was defined 
as fasting serum glucose ≥ 126 mg/dL, or being treated with insulin or other hypoglycemic agents. Hypercholes-
terolemia was defined as serum total cholesterol ≥ 200 mg/dL or receiving lipid-lowering treatment. Participants 
reported the following physician-diagnosed diseases: chronic lung disease (asthma or bronchitis), cardiovas-
cular disease (ischemic heart disease, congestive heart failure or stroke), cancer, depression and rheumatoid 
arthritis. Also, we asked participants about the routine use of non-steroidal anti-inflammatory medications, 
corticosteroids, immunomodulatory drugs, and beta interferon (because they can reduce inflammation mark-
ers), diuretics (because they can increase micronutrients excretion) and vitamin supplements. Information was 
checked against drug packages held at the participants´ homes.
Finally, blood level of high-sensitivity C-reactive protein (CRP) (mg/L) was measured by latex-enhanced 
nephelometry in the CBD in Barcelona.
Statistical analysis. Of the initial sample comprising 12,883 individuals, we excluded 758 because they 
used vitamin supplements and 1317 because they had missing or implausible data on any of the study variables. 
Thus, the analytical sample included 10,808 individuals, who were similar to the total study sample regarding 
socio-demographic, lifestyle and health status variables.
To examine the study associations, we used linear regression models with fibrinogen as the dependent vari-
able, and each of the following micronutrients intake (in quintiles) as the main independent variable: vitamin A, 
carotenoids, vitamin B6, vitamin C, vitamin D, vitamin E, magnesium, selenium, zinc and iron. Micronutrients 
were first adjusted for total energy intake using the residuals  method50. Next, participants were categorized into 
quintiles of each nutrient intake and quintile 1 (lowest) was used as the reference. Given that the fibrinogen levels 
did not follow a normal distribution, we used the log-transformed concentration; thus, we presented the geomet-
ric mean and its 95% confidence interval (CI) of plasma fibrinogen (g/L) across quintiles of the micronutrients 
dietary intake. We retained for further analyses those nutrients that in the basic linear regression model adjusted 
for age and sex (model 1) showed an association with the log-transformed fibrinogen (p < 0.10): carotenoids, 
vitamin B6, vitamin C, vitamin E, magnesium and iron. We then built three multivariate linear regression models 
with sequential adjustment for potential confounders: Model 1 adjusted for age and sex; model 2 additionally 
adjusted for educational level, smoking, heavy drinking, leisure-time physical activity, energy intake, obesity, 
chronic diseases (chronic lung disease, cardiovascular disease, cancer, depression, hypercholesterolemia, diabetes, 
hypertension and rheumatoid arthritis); and model 3 further adjusted for the rest of micronutrients and the fol-
lowing macronutrients (quintiles of intake after adjustment for total energy intake): fibre, carbohydrates, unsatu-
rated fats and sodium. To test the linear trend relationship between fibrinogen and each of the micronutrients of 
interest, we used the median value in each quintile of micronutrient intake as a continuous value in the models to 
obtain the P-value for linear trend of fibrinogen across the increasing quintiles of the micronutrients of interest.
We also replicated the analyses stratifying by abdominal obesity (yes/no) and age (≥ 60 and < 60 years). We 
tested if the results varied across strata, calculating a P-value for interaction, based on likelihood ratio tests that 
compared models with and without interaction terms.
Lastly, we conducted a sensitivity analysis rerunning the models after excluding participants taking anti-
inflammatory medications or diuretics.
Statistical significance was set at 2-tailed p ≤ 0.05. The analyses were performed using the “Survey Data” 
procedures of STATA software version 15 (StataCorp LP, College Station, Texas 77845 USA), which accounted 
for the complex sampling design in the study.
Results
The demographic, behavioral and clinical characteristics; macronutrients intake and blood levels of CRP, of the 
study participants across quintiles of fibrinogen concentration, are presented in Table 1. Compared to those in 
the lowest quintile of fibrinogen, participants in higher quintiles were older and less frequently men, had lower 
education, did less physical activity, more often had obesity and most of the diagnosed chronic diseases, had 
lower intake of the selected macronutrients and higher CRP levels (Table 1). Spearman correlation coefficients 
between the studied micronutrients intake were statistically significant in all cases and ranged from 0.27 to 0.84. 
Correlations between those micronutrients and plasma fibrinogen were rather small (Table 2). 
In age- and sex-adjusted analyses (model 1), we found an inverse association between quintiles of intake 
of all the studied micronutrients and fibrinogen level (Table 3). When analyses were further adjusted for all 
potential confounders but the rest of nutrients (model 2), the dose–response associations remained statistically 
significant only for vitamin E, magnesium and iron. The geometric means of fibrinogen (g/L) across increasing 
quintiles of nutrient intake were 3.22, 3.22, 3.22, 3.16, and 3.19 (p-trend = 0.030) for vitamin E; 3.23, 3.22, 3.20, 
3.19, and 3.19 (p-trend = 0.047) for magnesium; and 3.24, 3.22, 3.19, 3.21, and 3.19 (p-trend = 0.050) for iron. 
After additional adjustment for the rest of micronutrients and macronutrients (model 3), these associations lost 
statistical significance (Table 3).
In the stratified analyses (Table 4, model 2), the associations between vitamin E, magnesium and iron 
with fibrinogen levels were usually somewhat more marked among individuals with abdominal obesity and 
age ≥ 60 years; but in model 3 after adjustment for other nutrients, the significance of the main associations 
disappeared or their magnitude was extremely small (data not shown). In the sensitivity analyses with exclusion 
of participants taking anti-inflammatory medications and diuretics, the main results remained roughly similar, 
although they were even attenuated for the association between fibrinogen and iron intake in those with abdomi-
nal obesity (p for trend = 0.071) or ≥ 60 years (p for trend = 0.084).
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Discussion
Our results did not support a significant inverse dose–response association between the dietary intake of vitamin 
E, magnesium and iron with plasma fibrinogen concentrations after adjustment for other nutrients. In models 
with adjustment only for socio-demographic, behavioral and clinical characteristics, the inverse dose–response 
Table 1.  Characteristics of the study participants across quintiles of plasma fibrinogen in the ENRICA 
study (N = 10,808). SD standard deviation, MET metabolic equivalent, Kcal kilocalories, CRP high-sensitivity 
C-reactive protein. *P of the statistical significance differences between quintiles of plasma fibrinogen using 
the Chi-square, ANOVA or Kruskal–Wallis tests. a Average alcohol intake ≥ 40 g/day in men and ≥ 24 g/day 




Q 1 (lowest) (n = 2452) Q 2 (n = 2593) Q 3 (n = 1826) Q 4 (n = 1832) Q 5 (n = 2105)
Mean SD Mean SD Mean SD Mean SD Mean SD
Fibrinogen, (g/L) (mean with SD) 2.55 0.25 3.06 0.11 3.40 0.08 3.73 0.11 4.50 0.57
Age, y (mean with SD) 39.1 14.3 44.3 15.4 47.8 15.7 51.1 16.5 54.8 17.0 < 0.001
Sex, men% 61.4 52.8 47.1 42.6 40.0 < 0.001
Educational level, %
≤ Primary 18.0 23.8 29.5 35.8 40.6 < 0.001
Secondary 49.4 43.1 41.4 40.2 36.2
University 32.7 33.1 29.2 24.0 23.3
Smoking status, %
Never smoker 47.5 46.1 46.2 47.1 48.5 0.014
Former smoker 25.3 27.9 25.4 23.4 23.7
Current smoker 27.2 26.0 28.5 29.5 27.8
Heavy  drinkera, % 2.5 3.2 3.1 3.5 3.2 0.437
Leisure-time physical activity, METs-h/w (mean with SD) 33.5 24.8 30.0 22.6 27.0 20.7 24.4 18.5 23.0 18.5 < 0.001
Energy intake, kcal/d (mean with SD) 2361 652 2248 613 2188 614 2146 624 2093 630 < 0.001
Body Mass Indexb, %
Obesity 11.8 17.0 22.1 28.3 34.0 < 0.001
Morbidity, %
Chronic lung  diseasec 5.2 5.6 5.4 6.0 7.5 0.010
Cardiovascular  diseased 0.8 1.4 1.6 3.1 4.2 < 0.001
Cancer 0.5 0.5 0.6 1.3 1.9 < 0.001
Depression 4.0 5.4 6.7 8.7 9.3 < 0.001
Hypercholesterolemia 36.6 48.9 53.3 58.2 61.7 < 0.001
Diabetes 3.0 4.9 6.1 7.6 12.5 < 0.001
Hypertension 21.4 27.2 32.0 37.6 46.3 < 0.001
Rheumatoid arthritis 2.9 4.4 5.6 6.7 10.2 < 0.001
Fibre intake, (g/d) (mean with SD) 24.0 8.6 23.5 8.0 23.4 8.2 23.5 8.0 23.0 8.4 0.004
Carbohydrates intake, (g/d) (mean with SD) 244.4 77.2 232.4 72.1 226.9 72.7 224.2 72.0 221.5 73.4 < 0.001
Unsaturated fats intake, (g/d) (mean with SD) 17.1 7.9 16.2 7.6 15.5 7.5 15.2 7.3 14.6 7.4 < 0.001
Sodium intake, (mg/d) (mean with SD) 3217.3 1268.6 3056.4 1208.3 2973.3 1213.3 2994.9 1275.1 2917.9 1285.8 < 0.001
CRP, (mg/L) (mean with SD) 0.10 0.15 0.16 0.19 0.23 0.30 0.34 0.40 0.82 1.30 < 0.001
Table 2.  Spearman correlation coefficients among the micronutrients intake and fibrinogen. *p ≤ 0.05, 
**p < 0.01, ***p < 0.001.
Carotenoids Vitamin B6 Vitamin C Vitamin E Magnesium Iron Fibrinogen
Carotenoids 1.00 … … … … … …
Vitamin B6 0.40*** 1.00 … … … … …
Vitamin C 0.54*** 0.43*** 1.00 … … … …
Vitamin E 0.41*** 0.50*** 0.34*** 1.00 … … …
Magnesium 0.37*** 0.76*** 0.39*** 0.58*** 1.00 … …
Iron 0.31*** 0.76*** 0.27*** 0.55*** 0.84*** 1.00 …
Fibrinogen 0.02 − 0.08*** 0.04*** − 0.06*** − 0.08*** − 0.11*** 1.00
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associations of dietary intake of vitamin E, magnesium and iron with plasma fibrinogen concentrations were of 
very small magnitude; however, these small associations were slightly more marked in older adults and partici-
pants with abdominal obesity. This could be in line with the results from a meta-analysis of randomized trials 
where magnesium supplementation could decrease markers of inflammation only when they were previously 
 increased51, and with observations suggesting that people with obesity need higher magnesium intake to coun-
teract their chronic low-grade  inflammation23. However, in our study the magnitude of the studied associations, 
even for participants with abdominal obesity and aged ≥ 60 years, was small and even these associations were 
basically explained by the dietary intake of the rest of the nutrients, consequently their clinical implications are 
uncertain.
Our hypothesis had biological plausibility, although it was not robustly supported by the results. Specifically, 
vitamin E is a lipid-soluble antioxidant that preserves endothelial  function52. Also, vitamin E increases intracel-
lular free magnesium that protects against vascular damage caused by magnesium  deficiency53. Moreover, vita-
min E modulates the activity of enzymes and the expression of genes related to  atherosclerosis54. Given that the 
endothelium has an important physiological role that regulates the coagulation and the function of platelets and 
Table 3.  Geometric means of plasma concentration of fibrinogen by quintiles of micronutrient intake in the 
ENRICA study (N = 10,808). *p ≤ 0.05 **p < 0.01 ***p < 0.001. P values for differences in plasma fibrinogen 
levels across quintiles of micronutrients intake (quintile 1 as reference) using the above linear regression 
models. a Model 1: linear regression model adjusted for age and sex. b Model 2: adjusted as model 1 and for 
educational level (≤ Primary, Secondary, University), smoking status (never smoker, former smoker, current 
smoker), heavy drinking (yes, no), leisure-time physical activity (quintiles of METs-h/w), energy intake 
(quintiles of kcal/d), Body Mass Index ≥ 30 (yes, no), chronic lung disease, cardiovascular disease, cancer, 
depression, hypercholesterolemia, diabetes, hypertension and rheumatoid arthritis (yes, no). c Model 3: 
adjusted as model 2 and for fibre (quintiles of intake), carbohydrates (quintiles of intake), unsaturated fats 
(quintiles of intake), sodium (quintiles of intake) and all other micronutrients in the table (quintiles of intake).
Micronutrient intake
P for trend
Q 1 (lowest. 
Reference) 
(n = 2161)
Mean (g/L) (95% 
CI)
Q 2 (n = 2162)
Mean (g/L) (95% 
CI)
Q 3 (n = 2162)
Mean (g/L) (95% 
CI)
Q 4 (n = 2162)
Mean (g/L) (95% 
CI)
Q 5 (n = 2161)
Mean (g/L) (95% 
CI)
Carotenoids
Range (µg/d) < 1573 1573–2261 2261–2994 2994–4136 > 4136
Model  1a 3.26 (3.22; 3.29) 3.26 (3.17; 3.34) 3.20 (3.12; 3.29)* 3.22 (3.13; 3.30) 3.20 (3.12; 3.29)* 0.011
Model  2b 3.22 (3.15; 3.29) 3.23 (3.12; 3.35) 3.19 (3.07; 3.31) 3.20 (3.09; 3.32) 3.20 (3.08; 3.31) 0.222
Model  3c 3.19 (3.10; 3.28) 3.21 (3.07; 3.35) 3.17 (3.03; 3.32) 3.19 (3.05; 3.34) 3.20 (3.05; 3.35) 0.911
Vitamin B6
Range (mg/d) < 1.6 1.6–1.8 1.8–2.0 2.0–2.4 > 2.4
Model 1 3.26 (3.22; 3.30) 3.24 (3.16; 3.32) 3.22 (3.15; 3.31) 3.20 (3.12; 3.28)** 3.22 (3.14; 3.30) 0.043
Model 2 3.23 (3.16; 3.30) 3.21 (3.10; 3.33) 3.21 (3.10; 3.33) 3.18 (3.07; 3.30)** 3.21 (3.09; 3.33) 0.271
Model 3 3.19 (3.10; 3.28) 3.19 (3.05; 3.33) 3.20 (3.07; 3.35) 3.20 (3.05; 3.34) 3.24 (3.08; 3.40) 0.139
Vitamin C
Range (mg/d) < 64.0 64.0–90.6 90.6–118.1 118.1–161.0 > 161.0
Model 1 3.28 (3.24; 3.32) 3.21 (3.13; 3.29)** 3.25 (3.17; 3.33) 3.18 (3.10; 3.26)*** 3.22 (3.14; 3.30)** 0.004
Model 2 3.23 (3.16; 3.30) 3.19 (3.08; 3.31) 3.23 (3.12; 3.35) 3.17 (3.06; 3.29)* 3.22 (3.10; 3.33) 0.519
Model 3 3.19 (3.10; 3.28) 3.15 (3.02; 3.30) 3.20 (3.06; 3.34) 3.15 (3.01; 3.29) 3.19 (3.05; 3.35) 0.786
Vitamin E
Range (mg/d) < 7.0 7.0–8.8 8.8–10.4 10.4–12.9 > 12.9
Model 1 3.25 (3.22; 3.29) 3.25 (3.17; 3.34) 3.24 (3.16; 3.32) 3.18 (3.10; 3.26)** 3.20 (3.12; 3.28)* 0.001
Model 2 3.22 (3.15; 3.30) 3.22 (3.11; 3.35) 3.22 (3.10; 3.34) 3.16 (3.05; 3.28)** 3.19 (3.07; 3.31) 0.030
Model 3 3.19 (3.10; 3.28) 3.20 (3.07; 3.35) 3.20 (3.06; 3.35) 3.16 (3.02; 3.31) 3.18 (3.03; 3.34) 0.524
Magnesium
Range (mg/d) < 266.2 266.2–295.0 295.0–324.6 324.6–368.4 > 368.4
Model 1 3.27 (3.23; 3.31) 3.25 (3.17; 3.33) 3.22 (3.14; 3.30)* 3.20 (3.12; 3.29)** 3.19 (3.11; 3.28)** 0.001
Model 2 3.23 (3.16; 3.31) 3.22 (3.10; 3.33) 3.20 (3.09; 3.31) 3.19 (3.07; 3.30)* 3.19 (3.07; 3.31) 0.047
Model 3 3.19 (3.10; 3.28) 3.18 (3.04; 3.32) 3.17 (3.03; 3.32) 3.16 (3.02; 3.31) 3.17 (3.02; 3.33) 0.571
Iron
Range (mg/d)  < 11.5 11.5–12.7 12.7–13.7 13.7–15.3 > 15.3
Model 1 3.27 (3.23; 3.31) 3.24 (3.16; 3.32) 3.21 (3.13; 3.30)* 3.23 (3.14; 3.31) 3.19 (3.11; 3.28)** 0.003
Model 2 3.24 (3.16; 3.31) 3.22 (3.10; 3.34) 3.19 (3.08; 3.31) 3.21 (3.09; 3.33) 3.19 (3.07; 3.31) 0.050
Model 3 3.19 (3.10; 3.28) 3.17 (3.04; 3.31) 3.15 (3.01; 3.29) 3.16 (3.02; 3.31) 3.14 (2.99; 3.29) 0.114
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 monocytes52, the potential preservation of endothelial cell function by  magnesium27 and antioxidants like vita-
min E, among others, could stabilize inflammatory and coagulation  markers52, including fibrinogen. As regards 
magnesium, it is cofactor of over 600  enzymes55 involved in carbohydrate,  insulin53,56 and lipid  metabolism56. 
Moreover, low levels of magnesium are associated with: systemic inflammation (reduction of antiinflammatory 
and increase of inflammatory cytokines)57, activation of the hypothalamic–pituitary–adrenal  axis58, the meta-
bolic  syndrome56 and with endothelial  dysfunction59. Finally, iron-containing enzymes participate in the hepatic 
detoxification of exogenous  substances24, but when exceeding the physiological regulatory capacity, iron in this 
free form may act as a prooxidant  agent60. In any case, the relation between iron dietary intake and inflamma-
tion markers is complex and it could partially be explained by its original food source (heme or non-heme)32.
Few studies have previously assessed the association between the dietary intake of micronutrients and fibrino-
gen levels. Consistently with our results, Kim et al., in a 20-year follow-up of a cohort of young adults, found that 
magnesium intake (measured at years 0 and 7) was inversely associated with subsequent levels of  fibrinogen31. 
James et al. in a cross-sectional study of people aged ≥ 15 years, found that those with higher fibrinogen levels 
had significantly lower dietary intakes of iron and vitamin  E30. These findings are coherent with our results before 
adjustment for the rest of the nutrients.
By contrast, De Oliveira Otto et al. in a cross-sectional analysis found a direct association between dietary 
intake of magnesium and fibrinogen level, but the association lost significance after adjustment for the dietary 
intake of zinc and heme  iron32. However, no associations were found between fibrinogen levels and the dietary 
intakes of iron, zinc, vitamin C, vitamin E or β-carotene. These authors suggested that the inconsistencies assessed 
for some nutrient-marker relationship could be explained by the complexity of diet and the inherent difficulty to 
identify independent nutrient  associations32. Likewise, Wannamethee et al. in a cross-sectional study, reported 
that plasma levels, but not the dietary intake of vitamin C, had an inverse association with fibrinogen in older 
 men15; and Corley et al. in a cross-sectional study of adults ≥ 70 years reported inverse associations of the Mediter-
ranean dietary pattern and combined fruit and vegetable consumption with fibrinogen levels, but no association 
was observed for the dietary intake of vitamin C, vitamin E, β-carotene, zinc and  selenium33; although, neither 
of these studies analyzed the association with magnesium or iron.
Strengths and limitations. A main strength was the large study sample that was representative of the 
adult population of Spain. Also, food and nutrient intake was obtained through a validated diet history, and 
analyses were adjusted for many potential confounders. Our study has several limitations. First, the main limita-
tion was the cross-sectional study design, so the temporality of the associations is unknown and causal infer-
ence is limited. Second, fibrinogen was measured only once, so the associations might be underestimated due 
Table 4.  Geometric means of plasma concentration of fibrinogen by quintiles of micronutrient intake, 
stratified by abdominal obesity and age. Linear regression models adjusted as model 2 in Table 2. Please, note 
that each row depicts a separate model. a Waist circumference > 102 cm in men and > 88 cm in women. *p ≤ 0.05 
**p < 0.01 ***p < 0.001. P values for differences in plasma fibrinogen levels across quintiles of micronutrients 
intake (quintile 1 as reference) using the linear regression model.
Micronutrient intake
Q 1 (lowest 
Reference)
Mean (g/L) (95% CI)
Q 2
Mean (g/L) (95% CI)
Q 3
Mean (g/L) (95% CI)
Q 4
Mean (g/L) (95% CI)
Q 5
Mean (g/L) (95% CI) P for trend P for interaction
Stratified by abdominal obesity
Vitamin E
No abdominal obesity 3.18 (3.09; 3.27) 3.16 (3.01; 3.31) 3.17 (3.03; 3.32) 3.11 (2.96; 3.26)* 3.14 (2.99; 3.29) 0.086
0.323
Abdominal  obesitya 3.56 (3.44; 3.69) 3.59 (3.39; 3.81) 3.50 (3.30; 3.71) 3.50 (3.30; 3.71) 3.51 (3.31; 3.72) 0.052
Magnesium
No abdominal obesity 3.17 (3.08; 3.26) 3.16 (3.02; 3.31) 3.14 (3.00; 3.29) 3.16 (3.02; 3.31) 3.16 (3.01; 3.31) 0.824
< 0.001
Abdominal obesity 3.60 (3.48; 3.72) 3.52 (3.32; 3.73) 3.55 (3.35; 3.75) 3.46 (3.26;3.67)** 3.48 (3.28; 3.68)** 0.002
Iron
No abdominal obesity 3.17 (3.08; 3.26) 3.17 (3.03; 3.32) 3.14 (2.99; 3.29) 3.15 (3.01; 3.30) 3.14 (3.00; 3.30) 0.275
0.023
Abdominal obesity 3.61 (3.48; 3.73) 3.53 (3.33; 3.74) 3.52 (3.32; 3.74) 3.54 (3.34; 3.75) 3.49 (3.29; 3.70)** 0.016
Stratified by age
Vitamin E
Age < 60 y 3.14 (3.05; 3.22) 3.13 (3.00; 3.27) 3.12 (2.99; 3.26) 3.08 (2.96; 3.22)* 3.12 (2.99; 3.26) 0.250
0.175
Age ≥ 60 y 3.55 (3.40; 3.70) 3.54 (3.30; 3.79) 3.47 (3.24; 3.72) 3.44 (3.21; 3.70)* 3.46 (3.22; 3.70)* 0.012
Magnesium
Age < 60 y 3.14 (3.06; 3.23) 3.11 (2.99; 3.24) 3.11 (2.99; 3.24) 3.11 (2.98; 3.24) 3.13 (3.00; 3.26) 0.605
0.051
Age ≥ 60 y 3.56 (3.41; 3.71) 3.50 (3.27; 3.74) 3.52 (3.29; 3.77) 3.44 (3.20; 3.69)* 3.42 (3.19; 3.67)** 0.002
Iron
Age < 60 y 3.13 (3.05; 3.22) 3.12 (2.99; 3.26) 3.12 (2.99; 3.25) 3.12 (2.99; 3.26) 3.11 (2.98; 3.25) 0.361
0.458
Age ≥ 60 y 3.58 (3.43; 3.73) 3.51 (3.28; 3.76) 3.47 (3.23; 3.72)* 3.47 (3.24; 3.71)* 3.47 (3.23; 3.72)* 0.024
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to regression dilution bias. Moreover, if fibrinogen levels in some individuals reflected only an acute condition 
rather than a chronic inflammatory state, this might have also reduced the actual associations; however, this is 
likely to have had only a minor effect in our study because, according to the study protocol, participants with 
fever or other acute health problems postponed the blood draw until complete recovery. Third, simultaneous 
adjustment for micronutrients that share some food sources (e.g., green vegetables, whole grains and nuts are 
rich in vitamin E and magnesium) it is controversial, because it may represent an over-adjustment. Although 
the aim was to assess the independent association of each nutrient with fibrinogen, the fact was that mutual 
adjustment for all micronutrients led to a loss of statistical significance of the observed associations. Fourth, the 
fibrinogen range considered as normal in humans is 2–4 g/L, so most study participants were within the normal 
range. Some recent studies have found that age interacts with fibrinogen levels > 3.1 g/L to increase cognitive 
 impairment61, and that fibrinogen presents a significant continuous trend with the risk of cardiovascular  death62. 
Although we cannot completely rule out a benefit of reducing fibrinogen even in subjects with normal levels, the 
clinical significance of changes in fibrinogen within the normal range should be interpreted with caution. Fifth, 
we did not include in the models other nutrients like protein, total fat, vitamin A, vitamin D, selenium and zinc 
dietary intake as covariates. The rationale was that, although there was a theoretical ground to include most of 
them, they showed no association (p < 0.10) with the log-transformed fibrinogen in the basic linear regression 
model (model 1). Moreover, its inclusion in the adjusted models would have not provided any added value but 
would have decreased the parsimony of the model. Furthermore, since some of these nutrients, like vitamin A 
and zinc, were strongly correlated to some of the studied micronutrients, including them in the adjusted models 
would have produced data multicollinearity and thus, reduced the precision of the coefficient estimates and the 
statistical power. And sixth, despite using a validated diet history and excluding participants with an implausibly 
high or low energy intake level, certain misreporting and misclassification of micronutrient intake is possible. 
Moreover, recall of past food consumption may be distorted by current consumption, and certain social desir-
ability bias, which tends to over-represent the recall of healthy food, may also operate. These measurement errors 
usually tend to lead the observed associations towards the null.
Conclusions
The dietary intakes of Vitamin E, magnesium and iron were not inversely associated with lower fibrinogen levels 
after adjusting for other nutrients. However, in participants with abdominal obesity and aged ≥ 60 years the rela-
tion appeared to be slightly more prominent. Nevertheless, the magnitude of the observed associations was very 
small, even for older adults and participants with abdominal obesity, and virtually lost statistical significance 
after adjustment for other nutrients, so their clinical implications are uncertain.
Data availability
The datasets used and analyzed during the current study are available from the corresponding author on reason-
able request.
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